Vulcan’s $1B Raise Comes at a 34% Discount
Vulcan (ASX: VUL) announced today that it has completed its institutional placement at an offer price of A$4 per share. This represents a steep 34% discount to the last traded price of A$6.31 and a 21 percent discount to the theoretical ex-rights price of A$5.06. The institutional…
Market news
Step One Falls Flat
Step One (ASX: STP) experienced a heavy re-rating today, falling 35% in a single session. That is a substantial hit for any investor owning shares. The catalyst was the release of its H126 trading update, and the numbers came in well below expectations. Revenue is now forecast to land between A$30…
Australian GDP in Q3 shows that its economy is...complicated. Growth is stronger than last year, but the latest quarterly numbers fell short of expectations. Australia’s GDP rose by 0.4% in the September quarter, missing market expectations of 0.7%, according to data released by the Australian Bureau of Statistics. While annual GDP accelerated to 2.1%, the…
Montage Gold’s A$264m takeover ignites rally in African Gold
African Gold (ASX: A1G) has entered into a Scheme Implementation Deed with Montage Gold Corp, under which Montage will acquire African Gold in an all-scrip transaction. The announcement triggered a sharp 65% surge in African Gold’s share price.
Under the terms of the deal, African Gold shareholders…
AUB Group Takeover Talks Collapse, But Fundamentals Are Intact
AUB Group (ASX: AUB) saw its share price drop 15% today after announcing that takeover discussions with EQT AB and CVC Asia Pacific have been terminated. The talks had centred around a A$45.00 per share cash acquisition, which would have valued AUB at a premium, but…
Boss Energy (ASX: BOE) exploded 19.8% today in a single session, marking the biggest one-day gain since the uranium miner crashed 50% earlier this year. After months of being left for dead, the company delivered a September quarter producing 349,188 pounds of U₃O₈, which has traders reconsidering whether this beaten-down stock might actually survive.
What are…
Mayne Pharma in Freefall: Regulatory Hurdle Threatens $672 m Buy-out
Mayne Pharma (ASX: MYX) has suddenly become one of the most talked-about stocks on the ASX after the federal Treasurer raised serious national-interest concerns about its proposed takeover by Cosette Pharmaceuticals. The company that looked like it was on the cusp of being acquired is now…
China–US Rare Earth Deal: Short-Term Relief, Long-Term Opportunity
A major development unfolded this week as China and the United States reached a temporary truce following a meeting between Donald Trump and Xi Jinping at Busan Airport in South Korea. From an investor’s perspective, this is a significant moment for the rare earth sector and could…
RBA’s Balancing Act: How 3.2% Inflation Could Impact Your Investments
Inflation for September came in at 3.2% year-on-year, edging above the Reserve Bank of Australia’s 2–3% target band and marking the strongest gain in over a year since the June 2024 quarter. The Australian Bureau of Statistics noted that the main price pressures came from…
Dateline Resources Sinks 35% After Colosseum Project Update Disappoints Market Expectations
Dateline Resources (ASX: DTR) shares fell sharply today, closing down 35 percent after the company released its latest market update on the Colosseum Gold–Rare Earths Project in California. The announcement focused primarily on operational progress rather than new discoveries or production milestones, and…
